MAPK3 and cancer: Mechanistically, such behavioral changes were mediated by HML2 Env through the activation of ERK1/2 MAPK pathway (Figure 6) and the stimulation of transcription factors associated with cancer aggressiveness (Lemaître et al., 2017).